J. Guan, Q. Yang, C. Chen, G. Wang, and H. Zhu, “Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis”, EXCLI J., vol. 20, pp. 1–16, Jan. 2021.